Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridisation

被引:59
作者
Warren, C
James, LA
Ramsden, RT
Wallace, A
Baser, ME
Varley, JM
Evans, DG [1 ]
机构
[1] St Marys Hosp, Acad Unit Med Genet, Manchester M13 0JH, Lancs, England
[2] Paterson Inst Canc Res, Canc Res UK Dept Canc Genet, Manchester M20 9BX, Lancs, England
[3] Manchester Royal Infirm, ENT Dept, Manchester M13 9WL, Lancs, England
[4] St Marys Hosp, Reg Genet Serv, Manchester M13 0JH, Lancs, England
关键词
D O I
10.1136/jmg.40.11.802
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Schwannomas are benign tumours of the nervous system that are usually sporadic but also occur in the inherited disorder neurofibromatosis type 2 ( NF2). The NF2 gene is a tumour suppressor on chromosome 22. Loss of expression of the NF2 protein product, merlin, is universal in both sporadic and NF2 related schwannomas. The GTPase signalling molecules RhoA and Rac1 regulate merlin function, but to date only mutation in the NF2 gene has been identified as a causal event in schwannoma formation. Methods: Comparative genomic hybridisation ( CGH) was used to screen 76 vestibular schwannomas from 76 patients ( 66 sporadic and 10 NF2 related) to identify other chromosome regions that may harbour genes involved in the tumorigenesis. Results: The most common change was loss on chromosome 22, which was more frequent in sporadic than in NF2 related tumours. Importantly, eight tumours ( 10%) showed gain of copy number on chromosome 9q34. Each of the two NF2 patients who had received stereotactic radiotherapy had non- chromosome 22 changes, whereas only one of eight non- irradiated NF2 patients had any chromosome changes. Three tumours had gain on 17q, which has also been reported in malignant peripheral nerve sheath tumours that are associated with neurofibromatosis type 1. Other sites that were identified in three or fewer tumours were regions on chromosomes 10, 11, 13, 16, 19, 20, X, and Y. Conclusions: These findings should be verified using techniques that can detect smaller genetic changes, such as microarray- CGH.
引用
收藏
页码:802 / 806
页数:5
相关论文
共 51 条
[1]   CHARACTERIZATION OF A GUANINE-NUCLEOTIDE DISSOCIATION STIMULATOR FOR A RAS-RELATED GTPASE [J].
ALBRIGHT, CF ;
GIDDINGS, BW ;
LIU, J ;
VITO, M ;
WEINBERG, RA .
EMBO JOURNAL, 1993, 12 (01) :339-347
[2]   Genetic aberrations in sporadic and neurofibromatosis 2 (NF2)-associated schwannomas studied by comparative genomic hybridization (CGH) [J].
Antinheimo, J ;
Sallinen, SL ;
Sallinen, P ;
Haapasalo, H ;
Helin, H ;
Horelli-Kuitunen, N ;
Wessman, M ;
Sainio, M ;
Jääskeläinen, J ;
Carpén, O .
ACTA NEUROCHIRURGICA, 2000, 142 (10) :1099-1105
[3]  
Baser ME, 2000, BRIT J CANCER, V82, P998
[4]   VARIATION OF EXPRESSION OF THE GENE FOR TYPE-2 NEUROFIBROMATOSIS - ABSENCE OF A GENDER EFFECT ON VESTIBULAR SCHWANNOMAS, BUT CONFIRMATION OF A PREPONDERANCE OF MENINGIOMAS IN FEMALES [J].
EVANS, DGR ;
BLAIR, V ;
STRACHAN, T ;
LYE, RH ;
RAMSDEN, RT .
JOURNAL OF LARYNGOLOGY AND OTOLOGY, 1995, 109 (09) :830-835
[5]   A GENETIC-STUDY OF TYPE-2 NEUROFIBROMATOSIS IN THE UNITED-KINGDOM .1. PREVALENCE, MUTATION-RATE, FITNESS, AND CONFIRMATION OF MATERNAL TRANSMISSION EFFECT ON SEVERITY [J].
EVANS, DGR ;
HUSON, SM ;
DONNAI, D ;
NEARY, W ;
BLAIR, V ;
TEARE, D ;
NEWTON, V ;
STRACHAN, T ;
RAMSDEN, R ;
HARRIS, R .
JOURNAL OF MEDICAL GENETICS, 1992, 29 (12) :841-846
[6]   Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations [J].
Evans, DGR ;
Trueman, L ;
Wallace, A ;
Collins, S ;
Strachan, T .
JOURNAL OF MEDICAL GENETICS, 1998, 35 (06) :450-455
[7]  
EVANS DGR, 1992, Q J MED, V84, P603
[8]   Genome screening by comparative genomic hybridization [J].
Forozan, F ;
Karhu, R ;
Kononen, J ;
Kallioniemi, A ;
Kallioniemi, OP .
TRENDS IN GENETICS, 1997, 13 (10) :405-409
[9]   Chromosomal imbalances identified by comparative genomic hybridization in sporadic parathyroid adenomas [J].
García, JL ;
Tardío, JC ;
Gutiérrez, NC ;
González, MB ;
Polo, JR ;
Hernández, JM ;
Menárguez, J .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2002, 146 (02) :209-213
[10]  
Giovannini M, 2000, GENE DEV, V14, P1617